Late Breaking Abstract - First-time assessment of efficacy of candidate vaccine to prevent acute exacerbations of chronic obstructive pulmonary disease (AECOPD): multicentre, randomised, controlled, observer-blind phase 2b trial S. Andreas (Giessen, Germany), M. Testa (Siena, Italy), L. Boyer (Paris, France), G. Brusselle (Ghent, Belgium), W. Janssens (Leuven, Belgium), E. Kerwin (Medford, OR, United States of America), A. Papi (Ferrara, Italy), B. Pek (Québec, Canada), L. Puente-Maestu (Madrid, Spain), D. Saralaya (Bradford, United Kingdom), H. Watz (Grosshansdorf, Germany), T. Wilkinson (Southampton, United Kingdom), D. Casula (Siena, Italy), G. Di Maro (Siena, Italy), M. Lattanzi (Siena, Italy), L. Moraschini (Siena, Italy), S. Schoonbroodt (Rixensart, Belgium), A. Tasciotti (Siena, Italy), A. Arora (Siena, Italy), F. Maltais (Québec, Canada)
Source: Virtual Congress 2021 – ALERT: COPD
Session: ALERT: COPD Session type: Clinical trials sessionNumber: 210
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Andreas (Giessen, Germany), M. Testa (Siena, Italy), L. Boyer (Paris, France), G. Brusselle (Ghent, Belgium), W. Janssens (Leuven, Belgium), E. Kerwin (Medford, OR, United States of America), A. Papi (Ferrara, Italy), B. Pek (Québec, Canada), L. Puente-Maestu (Madrid, Spain), D. Saralaya (Bradford, United Kingdom), H. Watz (Grosshansdorf, Germany), T. Wilkinson (Southampton, United Kingdom), D. Casula (Siena, Italy), G. Di Maro (Siena, Italy), M. Lattanzi (Siena, Italy), L. Moraschini (Siena, Italy), S. Schoonbroodt (Rixensart, Belgium), A. Tasciotti (Siena, Italy), A. Arora (Siena, Italy), F. Maltais (Québec, Canada). Late Breaking Abstract - First-time assessment of efficacy of candidate vaccine to prevent acute exacerbations of chronic obstructive pulmonary disease (AECOPD): multicentre, randomised, controlled, observer-blind phase 2b trial. 210
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Early pulmonary rehabilitation after acute exacerbation of COPD: a randomised controlled trial Source: ERJ Open Res, 6 (1) 00173-2019; 10.1183/23120541.00173-2019 Year: 2020
Formoterol in patients with chronic obstructive pulmonary disease: a randomized, controlled, 3-month trial. Source: Eur Respir J 2002; 20: 245 Year: 2002
A prospective randomised double-blind placebo controlled trial of venlafaxine in patients with stable chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2006; 28: Suppl. 50, 32s Year: 2006
Effects of case management on hospitalisation and exacerbation rate in severe, complex COPD: A randomized controlled trial Source: Annual Congress 2011 - Exacerbations and severe chronic respiratory disease: oxygen, rehabilitation, admission to hospital and palliative care Year: 2011
Efficacy of moxifloxacin for treatment of bronchial colonisation in COPD patients: a randomised, double-blind, placebo-controlled study Source: Annual Congress 2007 - Treatment and care of COPD Year: 2007
RCT Abstract - Cyclophosphamide added to glucocorticoids in acute exacerbation of idiopathic pulmonary fibrosis (EXAFIP): a randomized, double-blind, placebo-controlled, phase 3 trial Source: Virtual Congress 2021 – ALERT: Asthma in adult, in children and ILDs Year: 2021
A multicentre randomised controlled trial of inspiratory muscle training for patients with chronic obstructive pulmonary disease (IMTCO study) Source: International Congress 2017 – Exercise training and breathing exercises in chronic respiratory disease Year: 2017
Effectiveness of non-invasive ventilation in stable chronic obstructive pulmonary disease with nocturnal desaturation: Prospective open-label randomized parallel-group study Source: Annual Congress 2013 –Long-term NIV: COPD, sleep, obesity and outcomes Year: 2013
Late Breaking Abstract - Astegolimab, an anti-ST2, in chronic obstructive pulmonary disease - COPD-ST2OP: a phase IIa, placebo-controlled trial Source: Virtual Congress 2021 – ALERT: COPD Year: 2021
ß-blockers in exacerbations of COPD: feasibility of a randomised controlled trial Source: ERJ Open Res, 3 (1) 00090-2016; 10.1183/23120541.00090-2016 Year: 2017
The utility of tiotropium among patients with chronic obstructive pulmonary disease (COPD): An updated meta-analysis of randomized controlled trials Source: Annual Congress 2013 –Quality of diagnosis and assessment in primary care Year: 2013
Heliox and alveolar oxygenation in patients with chronic obstructive pulmonary disease: a multicentre, randomised, crossover study Source: Eur Respir J 2004; 24: Suppl. 48, 243s Year: 2004
Antiplatelet therapy in the primary prevention of cardiovascular disease in patients with chronic obstructive pulmonary disease: a randomised controlled proof-of-concept trial Source: ERJ Open Res, 5 (3) 00110-2019; 10.1183/23120541.00110-2019 Year: 2019
Short term glucocorticoid therapy in acute exacerbations of chronic obstructive pulmonary disease: "REDUCE*", a non-inferiority multicenter trial. (*Red uction in the U se of C orticosteroids in E xacerbated COPD; ISRCTN19646069) Source: Annual Congress 2012 - Acute exacerbation in COPD Year: 2012
Edu-Care®, a randomised, multicentre study on education and quality of life in patients with chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2002; 20: Suppl. 38, 211s Year: 2002
RCT Abstract - Randomized, double-blind, placebo-controlled, phase III clinical trial with MV130, a sublingual bacterial immunotherapy to prevent COPD exacerbations Source: Virtual Congress 2021 – ALERT: COPD Year: 2021
Non-invasive positive pressure ventilation (NIPPV)for acute exacerbations of chronic obstructive pulmonary disease: a multicentre randomized controlled trial Source: Eur Respir J 2003; 22: Suppl. 45, 403s Year: 2003
Comprehensive care programme for patients with chronic obstructive pulmonary disease (COPD) --- A randomized controlled trial (RCT) Source: International Congress 2015 – Best abstracts in pulmonary rehabilitation and chronic care Year: 2015
A randomised controlled trial of individualised, progressed early exercise in patients hospitalised with an acute exacerbation of chronic obstructive pulmonary disease (AECOPD) Source: International Congress 2015 – Latest insights in pulmonary rehabilitation and functional capacity Year: 2015
Patient and carer preference in two models of care for acute exacerbation of chronic obstructive pulmonary disease: results of a randomized controlled trial Source: Eur Respir J 2001; 18: Suppl. 33, 24s Year: 2001